← Leaderboards
Bryan Koci
Eurofins Panlabs, Inc.
$3,480,946
Attributed
$3,480,946
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2020–22$2.5M$1.9M$1.3M$625K$0
'20
'21
'22
Funding mix
By agency
NIH$3,480,946 · 1
By mechanism
N01$3,480,946 · 1
Top collaborators
No co-investigators on record.
Most similar at Eurofins Panlabs, Inc.
Same institution · by research overlap
- Jacob Bode$2,367,927
- Anthony Gallagher$389,300
- Anthony Gallacher$585,330
- N N$12,000
- David Dean$18,273
Others in their field
Other Emerging Leaders on “Services”
- Leonard Freedman · Leidos Biomedical Research, Inc.$868,224,440
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lynn Briscoe · Leidos Biomedical Research, Inc.$245,116,298
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Leonard Freedmand · Leidos Biomedical Research, Inc.$184,354,216
- Joel A Lipkin · Four Points Technology, Llc$181,896,915
Research focus
ServicesTherapeutic DevelopmentPre-ClinicalInterventional Agent DevelopmentProgramsPathogenCommunicable DiseasesProduct DevelopmentDrug KineticsEvaluationSupport ContractsToxicologySafetyDevelopment PlansToxinChemistryIn VitroIn VivoLeadScreeningMicrobiologyLead OptimizationContractsNational Institute Of Allergy And Infectious Disease
Grant awards (11)
Task E11: Lead Optimization Screening Assays for ADMET, Safety Profiling, and Rodent Pharmacokinetics for the Antiviral Pandemic Preparedness Program (APP)$1,707,984
N01 · FY2022 · AI · contact PI
Task E12: Nonclinical Services for Development of Interventional Agents for Resistant Pathogens$406,123
N01 · FY2022 · AI · contact PI
Task E12: Nonclinical Services for Development of Interventional Agents for Infectious Diseases$135,375
N01 · FY2022 · AI · contact PI
Task E10: Lead Optimization Screening Assays for ADMET and Safety Profiling$197,984
N01 · FY2021 · AI · contact PI
Task E10: Lead Optimization Screening Assays for ADMET and Safety Profiling$49,496
N01 · FY2021 · AI · contact PI
Task E10: Lead Optimization Screening Assays for ADMET and Safety Profiling$16,498
N01 · FY2021 · AI · contact PI
Task E05: Lead Optimization Screening Assays for ADMET and Safety Profiling$348,342
N01 · FY2020 · AI · contact PI
Task E06: CUSTOM SCREENING ASSAYS FOR METABOLIC STABILITY AND PEPTIDASE SELECTIVITY$305,173
N01 · FY2020 · AI · contact PI
Task E05: Lead Optimization Screening Assays for ADMET and Safety Profiling$174,170
N01 · FY2020 · AI · contact PI
Task E06: CUSTOM SCREENING ASSAYS FOR METABOLIC STABILITY AND PEPTIDASE SELECTIVITY$93,991
N01 · FY2020 · AI · contact PI
Task E05: Lead Optimization Screening Assays for ADMET and Safety Profiling$45,810
N01 · FY2020 · AI · contact PI